Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma
Clinical trial NCT05990751 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05990751
- Sponsor
- University College, London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2026-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.